subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5706511

subject_name: Anti-B7-H3 Antibody-drug Conjugate YL201

object_name: non-small cell lung carcinoma

tested_intervention: unsure


subject: UMLS:C5706511

object_name: small cell lung carcinoma

tested_intervention: yes


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: cardiovascular disorder


subject: CHEBI:151315

subject_name: Heparin

object_name: Traumatic intracranial hemorrhage


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:3396

subject_name: Carbidopa-levodopa

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:3396

object_name: amyotrophic lateral sclerosis


subject: CHEBI:3396

object_name: motor neuron disorder


subject: UMLS:C0353697

subject_name: carbidopa / levodopa


subject: UMLS:C0353697


subject: UMLS:C0353697


subject: UMLS:C2718754

subject_name: Ilaris

object_name: arteriosclerosis disorder


subject: UMLS:C2718754

object_name: atherosclerosis


subject: UMLS:C2718754

object_name: Prediabetes


subject: UMLS:C5418057

object_name: breast neoplasm


subject: CHEBI:135552

subject_name: Prucalopride

object_name: Depressed mood


subject: CHEBI:135552

object_name: Cancer patients and suicide and depression


subject: CHEBI:135552

object_name: Depressed - symptom


subject: CHEBI:135552

object_name: Depression, CTCAE


subject: CHEBI:135552

object_name: mental disorder


subject: CHEBI:135552

object_name: psychiatric disorder


subject: CHEBI:135552

object_name: mood disorder


subject: UNII:QE1Q24M65Y

subject_name: Aramchol


subject: UNII:QE1Q24M65Y

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:QE1Q24M65Y

object_name: abdominal obesity-metabolic syndrome


subject: UNII:QE1Q24M65Y

object_name: metabolic syndrome X


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Childhood Solid Neoplasm


subject: CHEBI:41879

object_name: Adult Solid Neoplasm


subject: UNII:UVG3B5TZN3

subject_name: FARLETUZUMAB ECTERIBULIN


subject: UNII:UVG3B5TZN3


subject: UNII:UVG3B5TZN3

object_name: Solid Neoplasm


subject: UMLS:C4733601


subject: UMLS:C4733601


subject: UMLS:C4733601


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: UMLS:C4745461

subject_name: ABP 450

object_name: Glabellar frown lines


subject: CHEMBL.COMPOUND:CHEMBL2108531

subject_name: POLIFEPROSAN 20

object_name: Disseminated Malignant Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108531

object_name: Embolism, Tumor


subject: CHEMBL.COMPOUND:CHEMBL2108531

object_name: Neoplasm Metastasis


subject: CHEMBL.COMPOUND:CHEMBL2108531

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C0796325

subject_name: Carmustine Implant


subject: UMLS:C0796325


subject: UMLS:C0796325


subject: UMLS:C0796325


subject: MESH:C526315

object_name: Dementia associated with Parkinson's Disease


subject: MESH:C526315

object_name: Lewy Bodies


subject: CHEBI:2549

subject_name: Albuterol

object_name: diabetes mellitus


subject: CHEBI:5134

subject_name: Fluticasone


subject: CHEBI:141446

subject_name: Thr-Ile


subject: CHEBI:33341

subject_name: Titanium


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Rheumatic mitral stenosis


subject: CHEBI:70746

object_name: Mitral stenosis


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: UMLS:C5418065

subject_name: Basroparib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:90844

subject_name: Selexipag

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:90844

object_name: pulmonary hypertension


subject: CHEBI:90844

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:90844

object_name: pulmonary arterial hypertension


subject: MESH:D013607

subject_name: Tablets

object_name: HIV infection


subject: CHEBI:194531

subject_name: flerovium atom

object_name: adult glioblastoma


subject: CHEBI:194531

object_name: High grade glioma


subject: CHEBI:194531

object_name: malignant glioma


subject: CHEBI:190710

subject_name: Phe-Leu


subject: CHEBI:190710


subject: CHEBI:190710


subject: CHEBI:17051

subject_name: Fluoride ion


subject: CHEBI:17051


subject: CHEBI:17051


subject: UMLS:C1566771

subject_name: Lysosomal-Associated Membrane Proteins


subject: UMLS:C1566771


subject: UMLS:C1566771


subject: PR:000009951

subject_name: limbic system-associated membrane protein


subject: PR:000009951


subject: PR:000009951


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Solid Neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: DRUGBANK:DB17571

subject_name: Uzansertib


subject: UMLS:C4086723


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: UNII:N9B0H171MJ

subject_name: Derazantinib

object_name: intrahepatic cholangiocarcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: carcinoma


subject: UMLS:C3641122


subject: UNII:7DR7JMB8BH


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: UNII:MAF34143WM

object_name: ocular hypertension


subject: UNII:MAF34143WM

object_name: Ocular hypertension


subject: UNII:MAF34143WM

object_name: OPTN-related open angle glaucoma


subject: UNII:MAF34143WM

object_name: open-angle glaucoma


subject: UNII:MAF34143WM

object_name: exfoliation syndrome


subject: UNII:BK459F050X


subject: UMLS:C3657907

subject_name: VRC01 monoclonal antibody

object_name: Viral Load


subject: UMLS:C3657907

object_name: HIV-1 infection


subject: UMLS:C2745171

object_name: cataract


subject: UMLS:C2745171

object_name: Cataract, CTCAE 3.0


subject: UMLS:C2745171

object_name: Cataract, CTCAE 5.0


subject: UMLS:C2745171

object_name: cataract on exam (physical finding)


subject: UMLS:C2745171

object_name: Inflammation


subject: CHEBI:31485

subject_name: Difluprednate

object_name: dry eye syndrome


subject: CHEBI:25427

subject_name: mugineic acids

object_name: parenting status


subject: CHEBI:25427

object_name: Parenting (history)


subject: CHEBI:25427

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:25427


subject: CHEBI:233319

object_name: Advanced Synovial Sarcoma


subject: UMLS:C5556760

subject_name: BRD9 Degrader FHD-609


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: prostate carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: prostate cancer


subject: UMLS:C0879585

subject_name: prostatic acid phosphatase-sargramostim fusion protein


subject: UMLS:C0879585


subject: GTOPDB:8323

subject_name: monalizumab

object_name: Myelodysplasia


subject: GTOPDB:8323

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:8323

object_name: acute myeloid leukemia


subject: UNII:3ZXZ2V0588


subject: UNII:3ZXZ2V0588


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: UMLS:C3896730


subject: UMLS:C3896730


subject: CHEBI:45409

subject_name: Ritonavir

object_name: Hepatitis D, Chronic


subject: CHEBI:47097

subject_name: Lonafarnib


subject: CHEBI:52717

subject_name: Bortezomib

object_name: glioblastoma


subject: CHEBI:52717

object_name: Childhood Glioblastoma


subject: CHEBI:52717

object_name: adult glioblastoma


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: Immunosuppression


subject: MESH:D000086663

object_name: Decreased Immunologic Activity [PE]


subject: MESH:D000086663

object_name: autoimmune rheumatologic disease


subject: MESH:D000086663

object_name: rheumatoid arthritis


subject: MESH:D000086663

object_name: systemic sclerosis


subject: MESH:D000086663

object_name: vasculitis


subject: MESH:D000086663

object_name: Systemic Vasculitis


subject: MESH:D000086663

object_name: necrotizing vasculitis


subject: MESH:D000086663

object_name: undifferentiated connective tissue syndrome


subject: MESH:D000086663

object_name: EXCESS LMW-DNA


subject: MESH:D000086663

object_name: MASS syndrome


subject: MESH:D000086663

object_name: scleroderma


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: UMLS:C5400806


subject: CHEBI:50249

subject_name: anticoagulant

object_name: Physical trauma


subject: CHEBI:50249

object_name: Injury


subject: CHEBI:50249

object_name: Trauma


subject: CHEBI:50249

object_name: Hemorrhage


subject: CHEBI:50249

object_name: Intracranial hemorrhage


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0003280


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: sexual disorder


subject: UMLS:C0013227

object_name: physiological sexual disorder


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: GTOPDB:12790

subject_name: crovalimab

object_name: Guillain-Barre syndrome


subject: UNII:H9KH1GP3UU

subject_name: CROVALIMAB


subject: UMLS:C5418336


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:9831414

object_name: breast cancer


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: MESH:C579023

subject_name: AndoSan

object_name: inflammatory bowel disease


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Locally Advanced Unresectable Colorectal Adenocarcinoma


subject: UNII:PQX0D8J21J

object_name: KRAS Gene Mutation Negative


subject: UNII:PQX0D8J21J

object_name: NRAS Gene Mutation Negative


subject: UNII:PQX0D8J21J

object_name: BRAF V600E Negative


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:8988


subject: CHEBI:8988

object_name: Metastatic Colorectal Adenocarcinoma


subject: CHEBI:8988

object_name: Stage IIIC Colorectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIIB Colorectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Stage IIIA Colorectal Cancer AJCC v8


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: dehydration (Na, H2O)


subject: CHEBI:150712

object_name: Dehydration, CTCAE


subject: CHEBI:150712

object_name: Dehydration


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:75551

object_name: hyperlipidemia


subject: CHEBI:75551

object_name: hyperlipoproteinemia


subject: CHEBI:75551

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:75551

object_name: Serum lipids high (finding)


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: Duchenne muscular dystrophy


subject: CHEBI:3127

object_name: dilated cardiomyopathy


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: renal carcinoma


subject: UNII:GKF8S4C432

object_name: kidney neoplasm


subject: UNII:GKF8S4C432

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: renal cell adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Premenstrual Dysphoric Disorder


subject: CHEBI:5118

object_name: premenstrual tension


subject: CHEBI:5118

object_name: polydactyly-myopia syndrome


subject: CHEBI:85361

subject_name: tetramethylsilane

object_name: endogenous depression


subject: CHEBI:85361

object_name: major depressive disorder


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UNII:AQK7UBA1LS

object_name: aplastic anemia


subject: UNII:AQK7UBA1LS

object_name: idiopathic aplastic anemia


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: CHEBI:3219

subject_name: Bupropion

object_name: Drug Interactions


subject: CHEBI:3219

object_name: Adverse drug interaction


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:27732


subject: CHEBI:7772

subject_name: omeprazole


subject: CHEBI:7772


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:42446

subject_name: Esflurbiprofen


subject: CHEBI:42446


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: CHEBI:5130


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146178


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:5050

subject_name: Fexofenadine


subject: CHEBI:5050


subject: CHEBI:82715

object_name: rheumatoid arthritis


subject: UNII:FOF5155FMZ

object_name: head and neck squamous cell carcinoma


subject: UNII:FOF5155FMZ

object_name: Neck Carcinoma


subject: UNII:FOF5155FMZ

object_name: head and neck neoplasm


subject: UNII:FOF5155FMZ

object_name: head and neck cancer


subject: UNII:FOF5155FMZ

object_name: human papillomavirus-related squamous cell carcinoma


subject: UNII:FOF5155FMZ

object_name: Head and neck cancer stage IV


subject: UNII:FOF5155FMZ

object_name: Head and neck cancer stage III


subject: UNII:FOF5155FMZ

object_name: HPV-related carcinoma


subject: UNII:FOF5155FMZ

object_name: Human Papillomavirus-Related Malignant Neoplasm


subject: UNII:7JNY4KV3NK

subject_name: OCIPERLIMAB

object_name: Advanced Hepatocellular Carcinoma


subject: UMLS:C5417829

subject_name: Ociperlimab


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:50733

subject_name: nutraceutical

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:50733

object_name: obesity


subject: CHEBI:50733

object_name: Obesity, CTCAE


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: malignant glioma


subject: UNII:M89N0Q7EQR

object_name: brain cancer


subject: UNII:M89N0Q7EQR

object_name: brain neoplasm


subject: UNII:M89N0Q7EQR

object_name: glioblastoma


subject: UNII:M89N0Q7EQR

object_name: Childhood Glioblastoma


subject: UNII:M89N0Q7EQR

object_name: adult glioblastoma


subject: UNII:M89N0Q7EQR

object_name: Adult Gliosarcoma


subject: UNII:M89N0Q7EQR

object_name: gliosarcoma


subject: UNII:M89N0Q7EQR

object_name: Childhood Gliosarcoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UNII:RO03J093CP

subject_name: EPIDERMAL GROWTH FACTOR RECEPTOR


subject: UNII:RO03J093CP


subject: UNII:RO03J093CP


subject: UNII:RO03J093CP


subject: UNII:RO03J093CP


subject: UNII:RO03J093CP


subject: UNII:RO03J093CP


subject: UNII:RO03J093CP


subject: UNII:RO03J093CP


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: Insulin Sensitivity


subject: CHEBI:63638

object_name: type 2 diabetes mellitus


subject: CHEBI:63638

object_name: Insulin resistance


subject: CHEBI:63638

object_name: hyperinsulinism


subject: CHEBI:63638

object_name: Hyperinsulinemia


subject: CHEBI:63638

object_name: glucose intolerance


subject: CHEBI:63638

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:63638

object_name: hypertension


subject: CHEBI:63638

object_name: Hypertension, CTCAE


subject: UMLS:C3850285

object_name: chronic hepatitis C virus infection


subject: CHEBI:85182

subject_name: Dasabuvir


subject: UMLS:C3712108


subject: UMLS:C4053489

subject_name: Fluorine F 18 Fluorthanatrace

object_name: cancer


subject: UMLS:C4053489

object_name: neoplasm


subject: CHEBI:64816

object_name: Recurrent Sarcoma


subject: CHEBI:64816

object_name: Metastatic sarcoma


subject: CHEBI:64816

object_name: Resectable Sarcoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEMBL.COMPOUND:CHEMBL1743024

subject_name: GANITUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:71219

subject_name: Pazopanib


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:30742

subject_name: macrogol


subject: CHEBI:30742


subject: CHEBI:30742


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: MESH:C527545

subject_name: hMG-IBSA

object_name: Subfertility


subject: CHEBI:231674

object_name: non-Hodgkin lymphoma


subject: CHEBI:231674

object_name: diffuse large B-cell lymphoma


subject: CHEBI:231674

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:231674

object_name: Lymphoma, Large-Cell, Follicular


subject: CHEBI:231342

subject_name: ceralasertib


subject: CHEBI:231342


subject: CHEBI:231342


subject: CHEBI:231342


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3827158


subject: UMLS:C3640096


subject: UMLS:C3640096


subject: UMLS:C3640096


subject: UMLS:C3640096


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib


subject: PUBCHEM.COMPOUND:71226663


subject: PUBCHEM.COMPOUND:71226663


subject: UMLS:C3896840

subject_name: magrolimab


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:31898

subject_name: Nedaplatin

object_name: nasopharyngeal carcinoma


subject: CHEBI:31898

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEMBL.COMPOUND:CHEMBL3137685

subject_name: NEDAPLATIN


subject: CHEMBL.COMPOUND:CHEMBL3137685


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Small cell carcinoma, hypercalcemic type


subject: UNII:HVE36P8422

object_name: schizophrenia


subject: UNII:HVE36P8422

object_name: paranoid schizophrenia


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: breast neoplasm


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: pulmonary edema


subject: CHEBI:28787

object_name: Pulmonary Edema, CTCAE


subject: CHEBI:580604

subject_name: (R)-ketamine

object_name: Depressed mood


subject: CHEBI:580604

object_name: Cancer patients and suicide and depression


subject: CHEBI:580604

object_name: Depressed - symptom


subject: CHEBI:580604

object_name: Depression, CTCAE


subject: DRUGBANK:DB19150

subject_name: Arketamine


subject: DRUGBANK:DB19150


subject: DRUGBANK:DB19150


subject: DRUGBANK:DB19150


subject: CHEBI:60799

subject_name: Esketamine


subject: CHEBI:60799


subject: CHEBI:60799


subject: CHEBI:60799


subject: UMLS:C5392086

subject_name: Superparamagnetic Iron Oxide Nanoparticles

object_name: pediatric osteosarcoma


subject: UMLS:C5392086

object_name: Osteosarcoma


subject: CHEBI:139547

subject_name: superparamagnetic iron oxide nanoparticle


subject: CHEBI:139547


subject: UMLS:C2713972

subject_name: ZIO 101

object_name: plasma cell myeloma


subject: CHEBI:94295

subject_name: Darinaparsin


subject: CHEBI:33380

subject_name: thulium atom

object_name: hypertriglyceridemia


subject: CHEBI:33380

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: PUBCHEM.COMPOUND:3685

object_name: B-cell neoplasm


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: HIV infection


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: portal hypertension


subject: CHEBI:135949

object_name: Portal Hypertension, CTCAE


subject: CHEBI:135949

object_name: Cirrhosis


subject: CHEBI:135949

object_name: liver cirrhosis


subject: CHEBI:135949

object_name: Ascites


subject: CHEBI:135949

object_name: Ascites, CTCAE


subject: CHEBI:28875

subject_name: Myristic acid


subject: PUBCHEM.COMPOUND:40703

subject_name: PINAVERIUM BROMIDE

object_name: irritable bowel syndrome


subject: UNII:7SCF54H12J

subject_name: Pinaverium bromide [MI]


subject: CHEBI:135811

subject_name: Pinaverium


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:21874242

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:21874242

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:21874242

object_name: childhood bladder carcinoma


subject: UMLS:C0020855

subject_name: Immunoglobulin IgG1

object_name: non-small cell lung carcinoma


subject: UMLS:C0020855

object_name: prostate carcinoma


subject: UMLS:C0020855

object_name: prostate cancer


subject: UMLS:C0020855

object_name: carcinoma of esophagus


subject: UMLS:C0020855

object_name: esophageal cancer


subject: UMLS:C0020855

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C0020855

object_name: neoplasm of esophagus


subject: UMLS:C0020855

object_name: uterine cancer


subject: UMLS:C0020855

object_name: tumor of uterus


subject: UMLS:C0020855


subject: UMLS:C0020855


subject: UMLS:C0020855


subject: UMLS:C0020855


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: rectal neoplasm


subject: CHEBI:49603

subject_name: Lapatinib

object_name: triple-negative breast carcinoma


subject: CHEBI:82960

subject_name: Raltegravir

object_name: HIV-1 infection


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Gingival pigmentation


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:84500

subject_name: varenicline

object_name: Substance Use Disorders


subject: MESH:C000590839

subject_name: Shenghua Decoction

object_name: postpartum hemorrhage


subject: MESH:C000590839

object_name: Post-partum hemorrhage


subject: CHEBI:231425

subject_name: tolvaptan

object_name: Hyponatremia, CTCAE


subject: UNII:R60DZX1E2N

object_name: cancer


subject: UNII:R60DZX1E2N

object_name: neoplasm


subject: CHEBI:52763

object_name: Friedreich ataxia


subject: CHEBI:52763

object_name: Friedreich ataxia 1


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: rheumatoid arthritis


subject: HMDB:HMDB0014612

subject_name: Tenoxicam

object_name: migraine


subject: HMDB:HMDB0014612

object_name: migraine with or without aura, susceptibility to, 1


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: acute myeloid leukemia by FAB classification


subject: UNII:1C6V77QF41

object_name: acute myeloid leukemia


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:49005

subject_name: Deferasirox


subject: CHEBI:49005


subject: UNII:GK1LYB375A

subject_name: Tralokinumab

object_name: atopic eczema


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: Alzheimer disease type 1


subject: CHEBI:131701

object_name: Alzheimer disease


subject: UMLS:C2001395


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: psoriasis-related juvenile idiopathic arthritis


subject: UNII:09495UIM6V

object_name: enthesitis-related juvenile idiopathic arthritis


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: lymphomatoid papulosis


subject: UNII:7XL5ISS668

object_name: mycosis fungoides


subject: UNII:7XL5ISS668

object_name: Sezary syndrome


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C4525531

object_name: medullary thyroid gland carcinoma


subject: UMLS:C4525531

object_name: colon carcinoma


subject: UMLS:C4525531

object_name: colorectal cancer


subject: UMLS:C4525531

object_name: colon cancer


subject: UMLS:C4525531

object_name: non-small cell lung carcinoma


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UMLS:C0937629

subject_name: Gymnema sylvestre preparation

object_name: Prediabetes


subject: UMLS:C0937629

object_name: glucose intolerance


subject: UMLS:C0937629

object_name: Impaired glucose tolerance


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: malignant soft tissue neoplasm


subject: GTOPDB:9758

object_name: sarcoma


subject: GTOPDB:9758

object_name: Childhood Soft Tissue Sarcoma


subject: GTOPDB:9758

object_name: Adult Soft Tissue Sarcoma


subject: GTOPDB:9758

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: GTOPDB:9758

object_name: soft tissue sarcoma


subject: GTOPDB:9758

object_name: bone sarcoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: UNII:TWF0ML1CK8


subject: CHEBI:83800

subject_name: daclatasvir hydrochloride

object_name: Drug Interactions


subject: CHEBI:82977

subject_name: Daclatasvir


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Abortion early


subject: CHEBI:50692

object_name: pregnancy related


subject: UMLS:C5666891

subject_name: ATI 450

object_name: psoriatic arthritis


subject: UNII:1C6V77QF41

object_name: Executive dysfunction


subject: UNII:1C6V77QF41

object_name: Diabetes


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C0499050

subject_name: 5% DEXTROSE/WATER (500 ML = 1 UNIT) ADMINISTERED

object_name: biliary tract cancer


subject: UMLS:C0499050

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:168429725

subject_name: survodutide


subject: PUBCHEM.COMPOUND:168429725

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:168429725

object_name: obesity


subject: PUBCHEM.COMPOUND:168429725

object_name: Obesity, CTCAE


subject: UNII:2ALA66NS64

subject_name: SURVODUTIDE


subject: UNII:2ALA66NS64


subject: UNII:2ALA66NS64


subject: UNII:2ALA66NS64


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: atopic eczema


subject: UMLS:C0910794


subject: UMLS:C1831973

subject_name: Alpha-type-1 Polarized Dendritic Cells

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage II Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIA2 Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIA1 Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIA2 Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIA1 Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IVB Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IVA Primary Peritoneal Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIA Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage II Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage II Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIB Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IVB Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IVA Fallopian Tube Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IVA Ovarian Cancer AJCC v8


subject: UMLS:C1831973

object_name: Stage IVB Ovarian Cancer AJCC v8


subject: CHEBI:94809

subject_name: Itopride

object_name: Nonulcer dyspepsia


subject: CHEBI:3766

subject_name: Clozapine

object_name: Cannabis-Related Disorder


subject: CHEBI:3766

object_name: Cannabis-induced organic mental disorder


subject: CHEBI:3766

object_name: substance-related disorder


subject: CHEBI:499361

subject_name: Aprepitant

object_name: Post-Operative Pain


subject: UMLS:C3834167

subject_name: white tea extract

object_name: White spot lesions [initial caries] on smooth surface of tooth


subject: UMLS:C1568328

subject_name: CHIR 258

object_name: neoplasm


subject: UMLS:C1568328

object_name: cancer


subject: UNII:69VKY8P7EA


subject: UNII:69VKY8P7EA


subject: UMLS:C2004126

subject_name: TKI 258


subject: UMLS:C2004126


subject: CHEBI:50733

subject_name: nutraceutical

object_name: sarcopenia


subject: CHEBI:27446

subject_name: Penicillin V

object_name: peritonsillar abscess


subject: CHEBI:6909

subject_name: Metronidazole


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IIIA Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIA Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage I Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIB Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IA2 Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IA3 Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IB Lung Cancer AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IA1 Lung Cancer AJCC v8


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: UMLS:C4745070

subject_name: GSK-3 Inhibitor 9-ING-41

object_name: adrenal cortex carcinoma


subject: UMLS:C4745070

object_name: adenoid cystic carcinoma


subject: UMLS:C4745070

object_name: salivary gland carcinoma


subject: UMLS:C4745070

object_name: salivary gland cancer


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:76192587

subject_name: Ombitasvir

object_name: chronic hepatitis C virus infection


subject: CHEBI:85188

subject_name: paritaprevir


subject: CHEBI:8382

subject_name: Prednisone

object_name: asthma


subject: UMLS:C4085979

object_name: Childhood Breast Carcinoma


subject: UMLS:C4085979

object_name: breast carcinoma


subject: UMLS:C4085979

object_name: breast cancer


subject: UMLS:C4549041

object_name: pyropoikilocytosis, hereditary


subject: UMLS:C4549041

object_name: hypophosphatasia


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: psoriasis


subject: PUBCHEM.COMPOUND:9832804

subject_name: Enstilar


subject: CHEBI:90855


subject: RXCUI:1716093

subject_name: betamethasone / calcipotriene Topical Foam


subject: CHEBI:95165

object_name: Hematopoietic system--Cancer


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:76018

subject_name: Riociguat

object_name: acute mountain sickness


subject: CHEBI:76018

object_name: altitude sickness


subject: UMLS:C4733287

subject_name: Protein Tyrosine Kinase 2 Inhibitor BI 853520

object_name: neoplasm


subject: CHEBI:28680

subject_name: Cytarabine

object_name: CNS metastases


subject: CHEBI:28680

object_name: neoplastic meningitis


subject: CHEBI:28680

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:28680

object_name: Carcinoma breast stage IV


subject: CHEBI:28680

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:28680

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:28680

object_name: Breast cancer recurrent


subject: CHEBI:28680

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: acute kidney failure


subject: CHEBI:4466

object_name: Acute Kidney Injury, CTCAE


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UMLS:C5206860

subject_name: Rusfertide

object_name: acquired polycythemia vera


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: bladder tumor


subject: CHEBI:72317

object_name: urinary bladder carcinoma


subject: CHEBI:72317

object_name: urinary bladder cancer


subject: CHEBI:72317

object_name: childhood bladder carcinoma


subject: UMLS:C4548873

object_name: COPD, severe early onset


subject: UMLS:C4548873

object_name: chronic obstructive pulmonary disease


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:77562

object_name: Non-small cell lung cancer stage II


subject: CHEBI:77562

object_name: Stage IIIA Lung Cancer AJCC v8


subject: CHEBI:77562

object_name: Stage IIA Lung Cancer AJCC v8


subject: CHEBI:77562

object_name: Stage IIB Lung Cancer AJCC v8


subject: CHEBI:77562

object_name: Stage IB Non-Small Cell Lung Carcinoma AJCC v7


subject: CHEBI:77562

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:114785


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:6754

subject_name: Meperidine

object_name: Post-Operative Pain


subject: UMLS:C4331793

subject_name: Yang Yin Fang

object_name: cancer


subject: UMLS:C4331793

object_name: neoplasm


subject: UMLS:C4331794

subject_name: Yi Qi Fang


subject: UMLS:C4331794


subject: UMLS:C4331795

subject_name: Yi Qi Yang Yin Fang


subject: UMLS:C4331795


subject: UNII:19DG7G1U5Q

object_name: adult lymphoma


subject: UNII:19DG7G1U5Q

object_name: lymphoma


subject: UNII:19DG7G1U5Q

object_name: pediatric lymphoma


subject: UNII:19DG7G1U5Q

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:19DG7G1U5Q

object_name: T-Cell Lymphoma


subject: UNII:19DG7G1U5Q

object_name: Lymphoma, Low-Grade


subject: UNII:19DG7G1U5Q

object_name: Low grade (lymphoma grade) (finding)


subject: UNII:19DG7G1U5Q

object_name: mantle cell lymphoma


subject: UNII:19DG7G1U5Q

object_name: non-Hodgkin lymphoma


subject: UNII:19DG7G1U5Q

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UNII:19DG7G1U5Q

object_name: diffuse large B-cell lymphoma


subject: UNII:19DG7G1U5Q

object_name: Adult Diffuse Large Cell Lymphoma


subject: UNII:19DG7G1U5Q

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:19DG7G1U5Q

object_name: leukemia


subject: UNII:19DG7G1U5Q

object_name: childhood leukemia


subject: UNII:19DG7G1U5Q


subject: UNII:19DG7G1U5Q

object_name: cancer


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: fibrolamellar hepatocellular carcinoma


subject: UMLS:C0003442

object_name: liver carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UNII:0R1HN52K0N

subject_name: Padsevonil

object_name: Partial Seizure


subject: CHEBI:72296

subject_name: Apixaban

object_name: glioblastoma


subject: CHEBI:72296

object_name: Childhood Glioblastoma


subject: CHEBI:72296

object_name: adult glioblastoma


subject: CHEBI:72296

object_name: Childhood Astrocytoma


subject: CHEBI:72296

object_name: glioma susceptibility 1


subject: CHEBI:72296

object_name: astrocytic tumor


subject: CHEBI:72296

object_name: astrocytoma


subject: UMLS:C4287651

subject_name: Quadrivalent Inactivated Influenza Vaccine

object_name: streptococcal pneumonia


subject: CHEBI:43415

subject_name: Dexibuprofen

object_name: Upper Respiratory Infections


subject: CHEBI:43415

object_name: respiratory tract infectious disorder


subject: UNII:GE077RPG04

subject_name: RACLOPRIDE C 11

object_name: opiate dependence


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Trismus


subject: CHEBI:41879

object_name: Trismus, CTCAE


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Inflammation


subject: CHEBI:6888


subject: CHEBI:6888


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin


subject: PUBCHEM.COMPOUND:18772499

object_name: typhoid fever


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: CHEBI:3139

subject_name: bleomycin

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:233321

subject_name: Mitoquinone

object_name: viral respiratory tract infection


subject: UNII:K27MHH614O

subject_name: mitoquinol


subject: UNII:4UN9AOU6G8

object_name: interstitial lung disease 2


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: triple-negative breast carcinoma


subject: UNII:5S371K6132

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: proliferative diabetic retinopathy


subject: UMLS:C4331803

subject_name: MDM2-p53 Inhibitor APG-115

object_name: adult acute myeloid leukemia


subject: UMLS:C4331803

object_name: childhood acute myeloid leukemia


subject: UMLS:C4331803

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:435949

object_name: lymphoma


subject: PUBCHEM.COMPOUND:435949

object_name: pediatric lymphoma


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:74327


subject: UNII:1351PE5UGS

subject_name: Elotuzumab


subject: UNII:1351PE5UGS


subject: UNII:1351PE5UGS


subject: UMLS:C1541792

subject_name: Kanglaite Injection

object_name: non-small cell lung carcinoma


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: Injury of kidney


subject: CHEBI:6062

object_name: hypertension


subject: CHEBI:6062

object_name: Hypertension, CTCAE


subject: CHEBI:6062

object_name: proteinuria


subject: CHEBI:6062

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:6062

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:6062

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Immunosuppressant adverse reaction


subject: CHEBI:61049

object_name: cardiovascular disorder


subject: CHEBI:61049

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:61049

object_name: metabolic syndrome X


subject: CHEBI:52763

object_name: female infertility


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Alzheimer disease type 1


subject: UNII:M89N0Q7EQR

object_name: Alzheimer disease


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: rheumatoid arthritis


subject: UMLS:C1541395


subject: CHEBI:135207

subject_name: Clofedanol

object_name: precancerous condition


subject: CHEBI:15365

subject_name: Aspirin


subject: UMLS:C0034862

subject_name: Vaccines, Recombinant

object_name: human papilloma virus infection


subject: UMLS:C2987589


subject: CHEBI:18085

subject_name: glycosaminoglycan

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:18085

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:18085

object_name: metastatic melanoma


subject: CHEBI:18085

object_name: stage IIIA melanoma


subject: CHEBI:18085

object_name: stage IIIC melanoma


subject: CHEBI:18085

object_name: stage IIIB melanoma


subject: CHEBI:18085

object_name: Stage IIB Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:18085

object_name: stage IIB melanoma


subject: CHEBI:18085

object_name: stage IIA melanoma


subject: CHEBI:18085

object_name: stage IIC melanoma


subject: CHEBI:18085

object_name: Melanoma recurrent


subject: UMLS:C3669201

subject_name: GAG (Organic Chemical)


subject: UMLS:C3669201


subject: UMLS:C3669201


subject: UMLS:C3669201


subject: UMLS:C3669201


subject: UMLS:C3669201


subject: UMLS:C3669201


subject: UMLS:C3669201


subject: UMLS:C3669201


subject: UMLS:C3669201


subject: UMLS:C3669201


subject: CHEBI:143889

subject_name: galactosaminogalactan


subject: CHEBI:143889


subject: CHEBI:143889


subject: CHEBI:143889


subject: CHEBI:143889


subject: CHEBI:143889


subject: CHEBI:143889


subject: CHEBI:143889


subject: CHEBI:143889


subject: CHEBI:143889


subject: CHEBI:143889


subject: UniProtKB:P10405

subject_name: GAGY_DROME Retrovirus-related Gag polyprotein from transposon gypsy (sprot)


subject: UniProtKB:P10405


subject: UniProtKB:P10405


subject: UniProtKB:P10405


subject: UniProtKB:P10405


subject: UniProtKB:P10405


subject: UniProtKB:P10405


subject: UniProtKB:P10405


subject: UniProtKB:P10405


subject: UniProtKB:P10405


subject: UniProtKB:P10405


subject: UniProtKB:Q967S7

subject_name: GAGHB_DROME Retrovirus-related Gag polyprotein from transposon HMS-Beagle (sprot)


subject: UniProtKB:Q967S7


subject: UniProtKB:Q967S7


subject: UniProtKB:Q967S7


subject: UniProtKB:Q967S7


subject: UniProtKB:Q967S7


subject: UniProtKB:Q967S7


subject: UniProtKB:Q967S7


subject: UniProtKB:Q967S7


subject: UniProtKB:Q967S7


subject: UniProtKB:Q967S7


subject: UniProtKB:P04282

subject_name: GAG17_DROME Retrovirus-related Gag polyprotein from copia-like transposable element 17.6 (sprot)


subject: UniProtKB:P04282


subject: UniProtKB:P04282


subject: UniProtKB:P04282


subject: UniProtKB:P04282


subject: UniProtKB:P04282


subject: UniProtKB:P04282


subject: UniProtKB:P04282


subject: UniProtKB:P04282


subject: UniProtKB:P04282


subject: UniProtKB:P04282


subject: UniProtKB:P21330

subject_name: GAGJ_DROME Nucleic-acid-binding protein from mobile element jockey (sprot)


subject: UniProtKB:P21330


subject: UniProtKB:P21330


subject: UniProtKB:P21330


subject: UniProtKB:P21330


subject: UniProtKB:P21330


subject: UniProtKB:P21330


subject: UniProtKB:P21330


subject: UniProtKB:P21330


subject: UniProtKB:P21330


subject: UniProtKB:P21330


subject: UniProtKB:P20828

subject_name: GAG2_DROME Retrovirus-related Gag polyprotein from transposon 297 (sprot)


subject: UniProtKB:P20828


subject: UniProtKB:P20828


subject: UniProtKB:P20828


subject: UniProtKB:P20828


subject: UniProtKB:P20828


subject: UniProtKB:P20828


subject: UniProtKB:P20828


subject: UniProtKB:P20828


subject: UniProtKB:P20828


subject: UniProtKB:P20828


subject: UniProtKB:Q8I7Q0

subject_name: GAGO_DROME Retrovirus-related Gag polyprotein from transposon opus (sprot)


subject: UniProtKB:Q8I7Q0


subject: UniProtKB:Q8I7Q0


subject: UniProtKB:Q8I7Q0


subject: UniProtKB:Q8I7Q0


subject: UniProtKB:Q8I7Q0


subject: UniProtKB:Q8I7Q0


subject: UniProtKB:Q8I7Q0


subject: UniProtKB:Q8I7Q0


subject: UniProtKB:Q8I7Q0


subject: UniProtKB:Q8I7Q0


subject: PUBCHEM.COMPOUND:18375622

subject_name: MART-1 Antigen


subject: PUBCHEM.COMPOUND:18375622


subject: PUBCHEM.COMPOUND:18375622


subject: PUBCHEM.COMPOUND:18375622


subject: PUBCHEM.COMPOUND:18375622


subject: PUBCHEM.COMPOUND:18375622


subject: PUBCHEM.COMPOUND:18375622


subject: PUBCHEM.COMPOUND:18375622


subject: PUBCHEM.COMPOUND:18375622


subject: PUBCHEM.COMPOUND:18375622


subject: PUBCHEM.COMPOUND:18375622


subject: UMLS:C3146272

subject_name: MART-1 Antigen (vaccine component)


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C3146272


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: DRUGBANK:DB17475


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: CHEBI:36706

subject_name: Resiquimod


subject: CHEBI:36706


subject: CHEBI:36706


subject: CHEBI:36706


subject: CHEBI:36706


subject: CHEBI:36706


subject: CHEBI:36706


subject: CHEBI:36706


subject: CHEBI:36706


subject: CHEBI:36706


subject: CHEBI:36706


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: edema; macula


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:145588


subject: PUBCHEM.COMPOUND:168359761

subject_name: Chondroitin sulfate


subject: CHEBI:145591


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: UNII:UPC6BTX7PY

subject_name: INCLISIRAN SODIUM

object_name: cardiovascular disorder


subject: UNII:UPC6BTX7PY

object_name: arteriosclerosis disorder


subject: UNII:UPC6BTX7PY

object_name: atherosclerosis


subject: UNII:UPC6BTX7PY

object_name: Hypercholesterolemia


subject: GTOPDB:13624

subject_name: inclisiran


subject: GTOPDB:13624


subject: GTOPDB:13624


subject: CHEBI:189666

object_name: coronary artery disorder


subject: CHEBI:189666

object_name: coronary atherosclerosis


subject: CHEBI:189668

subject_name: Varespladib


subject: CHEBI:189668


subject: CHEBI:192805

subject_name: Varespladib methyl


subject: CHEBI:192805


subject: UMLS:C2742374


subject: UMLS:C2742374


subject: PUBCHEM.COMPOUND:9805430

subject_name: Apadenoson

object_name: heart disorder


subject: PUBCHEM.COMPOUND:9805430

object_name: myocardial ischemia


subject: PUBCHEM.COMPOUND:9805430

object_name: Family history of ischemic heart disease


subject: UNII:BTS1Y6777M


subject: UNII:BTS1Y6777M


subject: UNII:BTS1Y6777M


subject: PUBCHEM.COMPOUND:3222

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:3222

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:3222

object_name: breast cancer


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: UMLS:C0600128

subject_name: Renitec


subject: UMLS:C0600128


subject: UMLS:C0600128


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:157844

object_name: obesity


subject: CHEBI:157844

object_name: Obesity, CTCAE


subject: CHEBI:157844

object_name: type 2 diabetes mellitus


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: CHEBI:33379


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: PR:000007204


subject: PR:000007204


subject: CHEBI:177504

subject_name: Butylphthalide

object_name: moyamoya disease 1


subject: CHEBI:177504

object_name: Moyamoya disease


subject: CHEBI:177504

object_name: Ischaemic cerebral infarction


subject: CHEBI:177504

object_name: transient ischemic attack


subject: PR:000005679

subject_name: bifunctional coenzyme A synthase


subject: PR:000005679


subject: PR:000005679


subject: PR:000005679


subject: PR:000011476

subject_name: cytosolic Fe-S cluster assembly factor NUBP1


subject: PR:000011476


subject: PR:000011476


subject: PR:000011476


subject: UNII:0UXD5V5G6V

subject_name: CYCLOPENTOLATE HYDROCHLORIDE, (-)-

object_name: Visual Acuity


subject: UNII:736I6971TE

subject_name: CYCLOPENTOLATE HYDROCHLORIDE


subject: UNII:6D6X07D6BN

subject_name: CYCLOPENTOLATE HYDROCHLORIDE, (+)-


subject: CHEBI:4024

subject_name: Cyclopentolate


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: nephroblastoma


subject: CHEBI:72317

object_name: Wilms tumor


subject: CHEBI:72317

object_name: childhood kidney Wilms tumor


subject: CHEBI:72317

object_name: Refractory Wilms Tumor


subject: CHEBI:72317

object_name: Ewing sarcoma


subject: CHEBI:72317

object_name: Refractory Ewing Sarcoma


subject: CHEBI:72317

object_name: Ewing's sarcoma recurrent


subject: CHEBI:72317

object_name: Refractory Osteosarcoma


subject: CHEBI:72317

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:72317

object_name: Renal cell carcinoma recurrent


subject: CHEBI:72317

object_name: Osteosarcoma recurrent


subject: CHEBI:72317

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:72317

object_name: Recurrent Rhabdomyosarcoma


subject: CHEBI:72317

object_name: Refractory Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: Refractory Rhabdomyosarcoma


subject: CHEBI:72317

object_name: pediatric osteosarcoma


subject: CHEBI:72317

object_name: Osteosarcoma


subject: CHEBI:72317

object_name: Refractory Renal Cell Carcinoma


subject: CHEBI:72317

object_name: Refractory Hepatoblastoma


subject: CHEBI:72317

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: Recurrent Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: Refractory Clear Cell Sarcoma of Soft Tissue


subject: CHEBI:72317

object_name: Hepatoblastoma recurrent


subject: CHEBI:72317

object_name: Recurrent Clear Cell Sarcoma of Soft Tissue


subject: CHEBI:72317

object_name: Refractory Alveolar Soft Part Sarcoma


subject: CHEBI:72317

object_name: Childhood Clear Cell Sarcoma of Soft Parts


subject: CHEBI:72317

object_name: clear cell sarcoma


subject: CHEBI:72317

object_name: Alveolar soft part sarcoma recurrent


subject: CHEBI:72317

object_name: Refractory Adrenal Cortical Carcinoma


subject: CHEBI:72317

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: sarcoma


subject: CHEBI:72317

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:72317

object_name: soft tissue sarcoma


subject: CHEBI:72317

object_name: Refractory Hepatocellular Carcinoma


subject: CHEBI:72317

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:72317

object_name: renal cell adenocarcinoma


subject: CHEBI:72317

object_name: renal cell carcinoma


subject: CHEBI:72317

object_name: Recurrent Adrenal Cortical Carcinoma


subject: CHEBI:72317

object_name: Recurrent Hepatocellular Carcinoma


subject: CHEBI:72317

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:72317

object_name: rhabdomyosarcoma


subject: CHEBI:72317

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:72317

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:72317

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:72317

object_name: Refractory Thyroid Gland Medullary Carcinoma


subject: CHEBI:72317

object_name: Refractory Primary Central Nervous System Neoplasm


subject: CHEBI:72317

object_name: Recurrent Thyroid Gland Medullary Carcinoma


subject: CHEBI:72317

object_name: Refractory Primary Malignant Central Nervous System Neoplasm


subject: CHEBI:72317

object_name: alveolar soft part sarcoma


subject: CHEBI:72317

object_name: Recurrent Primary Malignant Central Nervous System Neoplasm


subject: CHEBI:72317

object_name: Adult Central Nervous System Neoplasm


subject: CHEBI:72317

object_name: Childhood Central Nervous System Neoplasm


subject: CHEBI:72317

object_name: central nervous system neoplasm


subject: CHEBI:72317

object_name: central nervous system cancer


subject: CHEBI:72317

object_name: Malignant neoplasm of the central nervous system


subject: CHEBI:72317

object_name: adrenal cortex carcinoma


subject: CHEBI:72317

object_name: hepatoblastoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Niemann-Pick disease type C


subject: CHEBI:31355

subject_name: Carboplatin

object_name: nasopharyngeal carcinoma


subject: CHEBI:31355


subject: CHEBI:31355

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR

object_name: mild neurocognitive disorder


subject: UNII:6867Q6IKOD

object_name: mild cognitive impairment


subject: CHEBI:36939

subject_name: Fluorine F-18


subject: CHEBI:36939


subject: UMLS:C3896800

subject_name: DNA (recombinant human telomerase-specific replication-competent oncolytic adenovirus 5 vector OBP-301)

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:141217


subject: CHEBI:141217

object_name: mood (physical finding)


subject: CHEBI:28969

subject_name: Dimethyltryptamine


subject: CHEBI:28969


subject: CHEBI:28121

subject_name: Harmine


subject: CHEBI:28121


subject: UNII:3412470A0V

subject_name: melflufen

object_name: Relapse multiple myeloma


subject: UNII:F70C5K4786

subject_name: Melphalan flufenamide


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:65353

object_name: obesity


subject: CHEBI:65353

object_name: Obesity, CTCAE


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: heart failure


subject: UNII:X587FW0372

object_name: Heart Failure, CTCAE


subject: CHEBI:142433

subject_name: Cinaciguat


subject: CHEBI:142433

object_name: congestive heart failure


subject: CHEBI:50662

subject_name: Marimastat

object_name: lung cancer


subject: CHEBI:50662

object_name: lung neoplasm


subject: CHEBI:50662

object_name: lung carcinoma


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Breech presentation


subject: CHEBI:8802

object_name: Pregnant


subject: GTOPDB:13826

subject_name: pegcetacoplan

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: GTOPDB:13826

object_name: amyotrophic lateral sclerosis


subject: GTOPDB:13826

object_name: motor neuron disorder


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: UNII:TO3JYR3BOU


subject: UNII:TO3JYR3BOU


subject: CHEBI:44915

subject_name: Propofol

object_name: colorectal carcinoma


subject: UMLS:C4726576

subject_name: Bet inhibitor cc-90010

object_name: glioblastoma


subject: UMLS:C4726576

object_name: Childhood Glioblastoma


subject: UMLS:C4726576

object_name: adult glioblastoma


subject: UMLS:C4726576

object_name: Childhood Astrocytoma


subject: UMLS:C4726576

object_name: glioma susceptibility 1


subject: UMLS:C4726576

object_name: astrocytic tumor


subject: UMLS:C4726576

object_name: astrocytoma


subject: UMLS:C2983753

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2983753

object_name: clear cell renal carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Refractory Colorectal Carcinoma


subject: CHEBI:4026

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: CHEBI:4026

object_name: Metastatic Colorectal Adenocarcinoma


subject: CHEBI:4026

object_name: Recurrent Ovarian Carcinosarcoma


subject: CHEBI:4026

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:4026

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: CHEBI:4026

object_name: Recurrent Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:4026

object_name: Malignant Solid Neoplasm


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Stage IV Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Platinum-Resistant Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C4079905

subject_name: andexanet

object_name: Hemorrhage


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: atrial fibrillation


subject: CHEBI:22652

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:22652

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:22652

object_name: Complications due to coronary artery bypass


subject: CHEBI:22652

object_name: Disorder of vitamin C


subject: CHEBI:22652

object_name: heart valve disorder


subject: CHEBI:18743

subject_name: (S)-2-trans-abscisic acid

object_name: rheumatoid arthritis


subject: CHEBI:2365

subject_name: Abscisic Acid


subject: CHEBI:53554

subject_name: 4,4'-azodibenzenearsonic acid


subject: CHEBI:28747

subject_name: Picolinic acid


subject: CHEBI:53407

subject_name: poly(lactic acid) macromolecule


subject: CHEBI:60159

subject_name: poly(lactic acid) polymer


subject: CHEBI:33349

subject_name: dubnium atom


subject: PR:000001875

subject_name: leptin receptor


subject: CHEBI:7852

subject_name: Oxycodone

object_name: osteoarthritis


subject: CHEBI:7459

subject_name: Naloxone


subject: UNII:1M8W6DVG0L

subject_name: BUTYRYLCHOLINESTERASE

object_name: colorectal disorders


subject: UNII:1M8W6DVG0L

object_name: colorectal neoplasm


subject: UMLS:C0728810

subject_name: Butyrylcholinesterase


subject: UMLS:C0728810


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: monoclonal gammopathy of uncertain significance


subject: UNII:T4H8FMA7IM

object_name: Plasma cell tumor, malignant


subject: UNII:T4H8FMA7IM

object_name: plasma cell neoplasm


subject: UMLS:C4521107

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C4521107

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C4521107

object_name: Pancreatic adenocarcinoma recurrent


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Glabellar frown lines


subject: UNII:0R4NLX88O4

subject_name: Taliglucerase alfa

object_name: Gaucher disease


subject: DRUGBANK:DB19270

object_name: Secondary malignant neoplasm of lung


subject: DRUGBANK:DB19270

object_name: Malignant neoplasm of stomach stage IV


subject: DRUGBANK:DB19270

object_name: Carcinoma breast stage IV


subject: DRUGBANK:DB19270

object_name: metastatic colorectal cancer


subject: UMLS:C2984517

subject_name: Saponin-based Immunoadjuvant OBI-821


subject: UMLS:C2984517


subject: UMLS:C2984517


subject: UMLS:C2984517


subject: CHEBI:39585

subject_name: Carbidopa

object_name: Diabetic peripheral neuropathic pain


subject: CHEBI:17553


subject: CHEBI:71464

subject_name: Palmidrol


subject: UMLS:C1572795

subject_name: PEA Preparation


subject: CHEBI:18397

subject_name: Phenethylamine


subject: DRUGBANK:DB10551

subject_name: Pea


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: PUBCHEM.COMPOUND:152165

object_name: Acute Pain


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:6129

subject_name: Ketorolac


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: adrenal gland pheochromocytoma


subject: UMLS:C3827032

object_name: pheochromocytoma


subject: UMLS:C3827032

object_name: paraganglioma


subject: CHEBI:71940

subject_name: Tadalafil

object_name: priapism


subject: CHEBI:71940

object_name: sickle cell disease


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: congenital heart malformation


subject: CHEBI:16480

object_name: congenital heart disease


subject: GTOPDB:2509

subject_name: NO


subject: GTOPDB:2509


subject: CHEBI:33396

subject_name: nobelium


subject: CHEBI:33396


subject: UMLS:C5891112

subject_name: PLZ4-coated Paclitaxel-loaded Micelle Formulation


subject: UMLS:C5891112


subject: PUBCHEM.COMPOUND:86280672

subject_name: POVORCITINIB

object_name: chronic idiopathic urticaria


subject: PUBCHEM.COMPOUND:86280672

object_name: urticaria


subject: PUBCHEM.COMPOUND:86280672

object_name: reported urticaria (physical finding)


subject: PUBCHEM.COMPOUND:86280672

object_name: Urticaria, CTCAE


subject: PUBCHEM.COMPOUND:86280672

object_name: angioedema


subject: PUBCHEM.COMPOUND:86280672

object_name: Pruritus


subject: UNII:N0JWC7RO00


subject: UNII:N0JWC7RO00


subject: UNII:N0JWC7RO00


subject: UNII:N0JWC7RO00


subject: UNII:N0JWC7RO00


subject: UNII:N0JWC7RO00


subject: UNII:M170940PMI

subject_name: anetumab ravtansine

object_name: lung neoplasm


subject: UMLS:C3273944

subject_name: Anti-mesothelin antibody-drug conjugate BAY 94-9343


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:3249

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:3249

object_name: breast cancer


subject: PUBCHEM.COMPOUND:3249

object_name: Adverse reactions


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UNII:ZV0MCR055T

object_name: heart failure


subject: UNII:ZV0MCR055T

object_name: Heart Failure, CTCAE


subject: UNII:ZV0MCR055T

object_name: Hypertensive heart and renal disease


subject: CHEBI:47381

object_name: osteoarthritis


subject: UNII:5B622U08B3

subject_name: Anhydrovinblastine

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:135145

subject_name: Neridronic Acid

object_name: complex regional pain syndrome


subject: CHEBI:4875

subject_name: Etanercept

object_name: Skin Diseases, Papulosquamous


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: type C thymoma


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: CHEBI:125628

subject_name: Alisertib

object_name: bladder tumor


subject: CHEBI:125628

object_name: urinary bladder carcinoma


subject: CHEBI:125628

object_name: urinary bladder cancer


subject: CHEBI:125628

object_name: childhood bladder carcinoma


subject: CHEBI:125628

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: pediatric lymphoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:51041

subject_name: Acamprosate

object_name: Psychophysiologic Disorders


subject: CHEBI:51041

object_name: Presenile dementia


subject: CHEBI:51041

object_name: dementia


subject: CHEBI:51041

object_name: anxiety disorder


subject: CHEBI:51041

object_name: Depressed mood


subject: CHEBI:51041

object_name: Cancer patients and suicide and depression


subject: CHEBI:51041

object_name: Depressed - symptom


subject: CHEBI:51041

object_name: Depression, CTCAE


subject: CHEBI:134990

subject_name: Agomelatine


subject: CHEBI:134990


subject: CHEBI:134990


subject: CHEBI:134990


subject: CHEBI:134990


subject: CHEBI:134990


subject: CHEBI:134990


subject: CHEBI:134990


subject: CHEBI:134990

object_name: schizophrenia


subject: CHEBI:2611

subject_name: Alprazolam


subject: CHEBI:2611


subject: CHEBI:2611


subject: CHEBI:2611


subject: CHEBI:2611


subject: CHEBI:2611


subject: CHEBI:2611


subject: CHEBI:2611


subject: CHEBI:9356

subject_name: Sultopride


subject: CHEBI:9356


subject: CHEBI:9356


subject: CHEBI:9356


subject: CHEBI:9356


subject: CHEBI:9356


subject: CHEBI:9356


subject: CHEBI:9356


subject: CHEBI:64045

subject_name: Amisulpride


subject: CHEBI:64045


subject: CHEBI:64045


subject: CHEBI:64045


subject: CHEBI:64045


subject: CHEBI:64045


subject: CHEBI:64045


subject: CHEBI:64045


subject: CHEBI:2666

subject_name: Amitriptyline


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:2666


subject: CHEBI:135224

subject_name: Amitriptylinoxide


subject: CHEBI:135224


subject: CHEBI:135224


subject: CHEBI:135224


subject: CHEBI:135224


subject: CHEBI:135224


subject: CHEBI:135224


subject: CHEBI:135224


subject: CHEBI:135224


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:31236


subject: CHEBI:31236


subject: CHEBI:31236


subject: CHEBI:93403

subject_name: Benperidol


subject: CHEBI:93403


subject: CHEBI:93403


subject: CHEBI:93403


subject: CHEBI:93403


subject: CHEBI:93403


subject: CHEBI:93403


subject: CHEBI:93403


subject: CHEBI:93403


subject: CHEBI:3112

subject_name: Biperiden


subject: CHEBI:3112


subject: CHEBI:3112


subject: CHEBI:3112


subject: CHEBI:3112


subject: CHEBI:3112


subject: CHEBI:3112


subject: CHEBI:3112


subject: CHEBI:3112


subject: CHEBI:31302

subject_name: Bromazepam


subject: CHEBI:31302


subject: CHEBI:31302


subject: CHEBI:31302


subject: CHEBI:31302


subject: CHEBI:31302


subject: CHEBI:31302


subject: CHEBI:31302


subject: CHEBI:31302


subject: CHEBI:31305

subject_name: Bromperidol


subject: CHEBI:31305


subject: CHEBI:31305


subject: CHEBI:31305


subject: CHEBI:31305


subject: CHEBI:31305


subject: CHEBI:31305


subject: CHEBI:31305


subject: CHEBI:31305


subject: CHEBI:31308

subject_name: Brotizolam


subject: CHEBI:31308


subject: CHEBI:31308


subject: CHEBI:31308


subject: CHEBI:31308


subject: CHEBI:31308


subject: CHEBI:31308


subject: CHEBI:31308


subject: CHEBI:31308


subject: CHEBI:3219

subject_name: Bupropion


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:3219


subject: CHEBI:3223

subject_name: Buspirone


subject: CHEBI:3223


subject: CHEBI:3223


subject: CHEBI:3223


subject: CHEBI:3223


subject: CHEBI:3223


subject: CHEBI:3223


subject: CHEBI:3223


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:8871


subject: CHEBI:3387

subject_name: Carbamazepine


subject: CHEBI:3387


subject: CHEBI:3387


subject: CHEBI:3387


subject: CHEBI:3387


subject: CHEBI:3387


subject: CHEBI:3387


subject: CHEBI:3387


subject: CHEBI:3387


subject: CHEBI:48814

subject_name: Chloral


subject: CHEBI:48814


subject: CHEBI:48814


subject: CHEBI:48814


subject: CHEBI:48814


subject: CHEBI:48814


subject: CHEBI:48814


subject: CHEBI:48814


subject: CHEBI:48814


subject: CHEBI:50932

subject_name: Chlorprothixene


subject: CHEBI:50932


subject: CHEBI:50932


subject: CHEBI:50932


subject: CHEBI:50932


subject: CHEBI:50932


subject: CHEBI:50932


subject: CHEBI:50932


subject: CHEBI:50932


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:31413

subject_name: Clobazam


subject: CHEBI:31413


subject: CHEBI:31413


subject: CHEBI:31413


subject: CHEBI:31413


subject: CHEBI:31413


subject: CHEBI:31413


subject: CHEBI:31413


subject: CHEBI:31413


subject: CHEBI:92875

subject_name: Clomethiazole


subject: CHEBI:92875


subject: CHEBI:92875


subject: CHEBI:92875


subject: CHEBI:92875


subject: CHEBI:92875


subject: CHEBI:92875


subject: CHEBI:92875


subject: CHEBI:92875


subject: CHEBI:47780

subject_name: Clomipramine


subject: CHEBI:47780


subject: CHEBI:47780


subject: CHEBI:47780


subject: CHEBI:47780


subject: CHEBI:47780


subject: CHEBI:47780


subject: CHEBI:47780


subject: CHEBI:47780


subject: CHEBI:3756

subject_name: Clonazepam


subject: CHEBI:3756


subject: CHEBI:3756


subject: CHEBI:3756


subject: CHEBI:3756


subject: CHEBI:3756


subject: CHEBI:3756


subject: CHEBI:3756


subject: CHEBI:3756


subject: CHEBI:3766

subject_name: Clozapine


subject: CHEBI:3766


subject: CHEBI:3766


subject: CHEBI:3766


subject: CHEBI:3766


subject: CHEBI:3766


subject: CHEBI:3766


subject: CHEBI:3766


subject: CHEBI:49575

subject_name: Diazepam


subject: CHEBI:49575


subject: CHEBI:49575


subject: CHEBI:49575


subject: CHEBI:49575


subject: CHEBI:49575


subject: CHEBI:49575


subject: CHEBI:49575


subject: CHEBI:49575


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:145499

subject_name: Donepezil


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499


subject: CHEBI:145499


subject: UNII:851NLB57HQ

subject_name: E-DOXEPIN


subject: UNII:851NLB57HQ


subject: UNII:851NLB57HQ


subject: UNII:851NLB57HQ


subject: UNII:851NLB57HQ


subject: UNII:851NLB57HQ


subject: UNII:851NLB57HQ


subject: UNII:851NLB57HQ


subject: UNII:851NLB57HQ


subject: CHEBI:4710

subject_name: Doxepin


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:36796

subject_name: duloxetine


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:36796


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:5118


subject: CHEBI:93235

subject_name: flupentixol


subject: CHEBI:93235


subject: CHEBI:93235


subject: CHEBI:93235


subject: CHEBI:93235


subject: CHEBI:93235


subject: CHEBI:93235


subject: CHEBI:93235


subject: CHEBI:93235


subject: CHEBI:5121

subject_name: flupenthixol


subject: CHEBI:5121


subject: CHEBI:5121


subject: CHEBI:5121


subject: CHEBI:5121


subject: CHEBI:5121


subject: CHEBI:5121


subject: CHEBI:5121


subject: CHEBI:5121


subject: CHEBI:5123

subject_name: Fluphenazine


subject: CHEBI:5123


subject: CHEBI:5123


subject: CHEBI:5123


subject: CHEBI:5123


subject: CHEBI:5123


subject: CHEBI:5123


subject: CHEBI:5123


subject: CHEBI:5123


subject: CHEBI:5128

subject_name: Flurazepam


subject: CHEBI:5128


subject: CHEBI:5128


subject: CHEBI:5128


subject: CHEBI:5128


subject: CHEBI:5128


subject: CHEBI:5128


subject: CHEBI:5128


subject: CHEBI:5128


subject: CHEBI:93369

subject_name: Fluspirilene


subject: CHEBI:93369


subject: CHEBI:93369


subject: CHEBI:93369


subject: CHEBI:93369


subject: CHEBI:93369


subject: CHEBI:93369


subject: CHEBI:93369


subject: CHEBI:93369


subject: CHEBI:93274

subject_name: Fluvoxamine


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:93274


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42944

subject_name: Galantamine


subject: CHEBI:42944


subject: CHEBI:42944


subject: CHEBI:42944


subject: CHEBI:42944


subject: CHEBI:42944


subject: CHEBI:5613

subject_name: Haloperidol


subject: CHEBI:5613


subject: CHEBI:5613


subject: CHEBI:5613


subject: CHEBI:5613


subject: CHEBI:5613


subject: CHEBI:5613


subject: CHEBI:5613


subject: CHEBI:5613


subject: CHEBI:5818

subject_name: Hydroxyzine


subject: CHEBI:5818


subject: CHEBI:5818


subject: CHEBI:5818


subject: CHEBI:5818


subject: CHEBI:5818


subject: CHEBI:5818


subject: CHEBI:5818


subject: CHEBI:5818


subject: CHEBI:47499

subject_name: Imipramine


subject: CHEBI:47499


subject: CHEBI:47499


subject: CHEBI:47499


subject: CHEBI:47499


subject: CHEBI:47499


subject: CHEBI:47499


subject: CHEBI:47499


subject: CHEBI:47499


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: PUBCHEM.COMPOUND:21634109


subject: CHEBI:6367

subject_name: Lamotrigine


subject: CHEBI:6367


subject: CHEBI:6367


subject: CHEBI:6367


subject: CHEBI:6367


subject: CHEBI:6367


subject: CHEBI:6367


subject: CHEBI:6367


subject: CHEBI:6367


subject: CHEBI:176724

subject_name: Etiracetam


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: CHEBI:176724


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: CHEBI:6437


subject: PUBCHEM.COMPOUND:3916

subject_name: Levopromazine


subject: PUBCHEM.COMPOUND:3916


subject: PUBCHEM.COMPOUND:3916


subject: PUBCHEM.COMPOUND:3916


subject: PUBCHEM.COMPOUND:3916


subject: PUBCHEM.COMPOUND:3916


subject: PUBCHEM.COMPOUND:3916


subject: PUBCHEM.COMPOUND:3916


subject: PUBCHEM.COMPOUND:3916


subject: CHEBI:6838

subject_name: levomepromazine


subject: CHEBI:6838


subject: CHEBI:6838


subject: CHEBI:6838


subject: CHEBI:6838


subject: CHEBI:6838


subject: CHEBI:6838


subject: CHEBI:6838


subject: CHEBI:6838


subject: CHEBI:30145

subject_name: lithium atom


subject: CHEBI:30145


subject: CHEBI:30145


subject: CHEBI:30145


subject: CHEBI:30145


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: UMLS:C3540800


subject: CHEBI:52993

subject_name: Lormetazepam


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:52993


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6539


subject: CHEBI:6690

subject_name: Maprotiline


subject: CHEBI:6690


subject: CHEBI:6690


subject: CHEBI:6690


subject: CHEBI:6690


subject: CHEBI:6690


subject: CHEBI:6690


subject: CHEBI:6690


subject: CHEBI:6690


subject: UMLS:C1527137

subject_name: Recombinant melatonin


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: UMLS:C1527137


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:93626

subject_name: Melperone


subject: CHEBI:93626


subject: CHEBI:93626


subject: CHEBI:93626


subject: CHEBI:93626


subject: CHEBI:93626


subject: CHEBI:93626


subject: CHEBI:93626


subject: CHEBI:93626


subject: CHEBI:64312

subject_name: Memantine


subject: CHEBI:64312


subject: CHEBI:64312


subject: CHEBI:51137

subject_name: Mianserin


subject: CHEBI:51137


subject: CHEBI:51137


subject: CHEBI:51137


subject: CHEBI:51137


subject: CHEBI:51137


subject: CHEBI:51137


subject: CHEBI:51137


subject: CHEBI:51137


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6950

subject_name: Mirtazapine


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:83531

subject_name: Moclobemide


subject: CHEBI:83531


subject: CHEBI:83531


subject: CHEBI:83531


subject: CHEBI:83531


subject: CHEBI:83531


subject: CHEBI:83531


subject: CHEBI:83531


subject: CHEBI:83531


subject: CHEBI:31902

subject_name: Nicergoline


subject: CHEBI:31902


subject: CHEBI:31902


subject: CHEBI:31902


subject: CHEBI:31902


subject: CHEBI:31902


subject: CHEBI:31902


subject: CHEBI:31902


subject: CHEBI:31902


subject: CHEBI:7581

subject_name: Nitrazepam


subject: CHEBI:7581


subject: CHEBI:7581


subject: CHEBI:7581


subject: CHEBI:7581


subject: CHEBI:7581


subject: CHEBI:7581


subject: CHEBI:7581


subject: CHEBI:7581


subject: CHEBI:7640

subject_name: Nortriptyline


subject: CHEBI:7640


subject: CHEBI:7640


subject: CHEBI:7640


subject: CHEBI:7640


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:94534


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:7476


subject: CHEBI:94614

subject_name: Opipramol


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:94614


subject: CHEBI:7823

subject_name: Oxazepam


subject: CHEBI:7823


subject: CHEBI:7823


subject: CHEBI:7823


subject: CHEBI:7823


subject: CHEBI:7823


subject: CHEBI:7823


subject: CHEBI:7823


subject: CHEBI:7823


subject: CHEBI:7824

subject_name: Oxcarbazepine


subject: CHEBI:7824


subject: CHEBI:7824


subject: CHEBI:7824


subject: CHEBI:7824


subject: CHEBI:7824


subject: CHEBI:7824


subject: CHEBI:7824


subject: CHEBI:82978

subject_name: paliperidone


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:82978


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:83804


subject: CHEBI:7936

subject_name: Paroxetine


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:7936


subject: CHEBI:59118

subject_name: Perazine


subject: CHEBI:59118


subject: CHEBI:59118


subject: CHEBI:59118


subject: CHEBI:59118


subject: CHEBI:59118


subject: CHEBI:59118


subject: CHEBI:59118


subject: CHEBI:59118


subject: CHEBI:8028

subject_name: Perphenazine


subject: CHEBI:8028


subject: CHEBI:8028


subject: CHEBI:8028


subject: CHEBI:8028


subject: CHEBI:8028


subject: CHEBI:8028


subject: CHEBI:8028


subject: CHEBI:8028


subject: CHEBI:8069

subject_name: Phenobarbital


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8069


subject: CHEBI:8107

subject_name: Phenytoin


subject: CHEBI:8107


subject: CHEBI:8107


subject: CHEBI:8107


subject: CHEBI:8107


subject: CHEBI:8212

subject_name: Pimozide


subject: CHEBI:8212


subject: CHEBI:8212


subject: CHEBI:8212


subject: CHEBI:8212


subject: CHEBI:8212


subject: CHEBI:8212


subject: CHEBI:8212


subject: CHEBI:8212


subject: CHEBI:78549

subject_name: Pipamperone


subject: CHEBI:78549


subject: CHEBI:78549


subject: CHEBI:78549


subject: CHEBI:32010

subject_name: Piracetam


subject: CHEBI:32010


subject: CHEBI:32010


subject: CHEBI:32010


subject: CHEBI:32010


subject: CHEBI:32010


subject: CHEBI:32010


subject: CHEBI:32010


subject: CHEBI:32010


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: PUBCHEM.COMPOUND:4715169


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:64356


subject: CHEBI:8461

subject_name: Promethazine


subject: CHEBI:8461


subject: CHEBI:8461


subject: CHEBI:8461


subject: CHEBI:8461


subject: CHEBI:8461


subject: CHEBI:8461


subject: CHEBI:8461


subject: CHEBI:8461


subject: CHEBI:135182

subject_name: Prothipendyl


subject: CHEBI:135182


subject: CHEBI:135182


subject: CHEBI:135182


subject: CHEBI:135182


subject: CHEBI:135182


subject: CHEBI:135182


subject: CHEBI:135182


subject: CHEBI:135182


subject: CHEBI:135554

subject_name: Pyritinol


subject: CHEBI:135554


subject: CHEBI:135554


subject: CHEBI:135554


subject: CHEBI:135554


subject: CHEBI:135554


subject: CHEBI:135554


subject: CHEBI:135554


subject: CHEBI:135554


subject: CHEBI:8707

subject_name: Quetiapine


subject: CHEBI:8707


subject: CHEBI:8707


subject: CHEBI:125535

subject_name: Esreboxetine


subject: CHEBI:125535


subject: CHEBI:125535


subject: CHEBI:125535


subject: CHEBI:125535


subject: CHEBI:125535


subject: CHEBI:125535


subject: CHEBI:125535


subject: CHEBI:125535


subject: CHEBI:135342

subject_name: Reboxetine


subject: CHEBI:135342


subject: CHEBI:135342


subject: CHEBI:135342


subject: CHEBI:135342


subject: CHEBI:135342


subject: CHEBI:135342


subject: CHEBI:135342


subject: CHEBI:135342


subject: CHEBI:8874

subject_name: Rivastigmine


subject: CHEBI:8874


subject: CHEBI:8874


subject: CHEBI:8874


subject: CHEBI:8874


subject: CHEBI:8874


subject: CHEBI:8874


subject: CHEBI:8874


subject: CHEBI:8874


subject: CHEBI:9122

subject_name: Sertindole


subject: CHEBI:9122


subject: CHEBI:9122


subject: CHEBI:9122


subject: CHEBI:9122


subject: CHEBI:9122


subject: CHEBI:9122


subject: CHEBI:9122


subject: CHEBI:9122


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEBI:9123


subject: CHEBI:9123


subject: CHEBI:9123


subject: CHEBI:32168

subject_name: Sulpiride


subject: CHEBI:32168


subject: CHEBI:32168


subject: CHEBI:32168


subject: CHEBI:32168


subject: CHEBI:32168


subject: CHEBI:32168


subject: CHEBI:32168


subject: CHEBI:32168


subject: CHEBI:9435

subject_name: Temazepam


subject: CHEBI:9435


subject: CHEBI:9435


subject: CHEBI:9435


subject: CHEBI:9435


subject: CHEBI:9435


subject: CHEBI:9435


subject: CHEBI:9435


subject: CHEBI:9435


subject: CHEBI:9566

subject_name: Thioridazine


subject: CHEBI:9566


subject: CHEBI:9566


subject: CHEBI:9566


subject: CHEBI:9566


subject: CHEBI:9566


subject: CHEBI:9566


subject: CHEBI:9566


subject: CHEBI:9566


subject: CHEBI:94666

subject_name: Tiapride


subject: CHEBI:94666


subject: CHEBI:94666


subject: CHEBI:94666


subject: CHEBI:94666


subject: CHEBI:94666


subject: CHEBI:94666


subject: CHEBI:94666


subject: CHEBI:94666


subject: CHEBI:63631

subject_name: Topiramate


subject: CHEBI:63631


subject: CHEBI:63631


subject: CHEBI:63631


subject: CHEBI:63631


subject: CHEBI:63631


subject: CHEBI:63631


subject: CHEBI:63631


subject: PUBCHEM.COMPOUND:73417116

subject_name: TRANYLCYPROMINE


subject: PUBCHEM.COMPOUND:73417116


subject: PUBCHEM.COMPOUND:73417116


subject: PUBCHEM.COMPOUND:73417116


subject: PUBCHEM.COMPOUND:73417116


subject: PUBCHEM.COMPOUND:73417116


subject: PUBCHEM.COMPOUND:73417116


subject: PUBCHEM.COMPOUND:73417116


subject: PUBCHEM.COMPOUND:73417116


subject: CHEBI:182949

subject_name: Tranylcypromine


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:182949


subject: CHEBI:9654

subject_name: Trazodone


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9654


subject: CHEBI:9674

subject_name: Triazolam


subject: CHEBI:9674


subject: CHEBI:9674


subject: CHEBI:9674


subject: CHEBI:9674


subject: CHEBI:9674


subject: CHEBI:9674


subject: CHEBI:9674


subject: CHEBI:9674


subject: CHEBI:9738

subject_name: Trimipramine


subject: CHEBI:9738


subject: CHEBI:9738


subject: CHEBI:9738


subject: CHEBI:9738


subject: CHEBI:9738


subject: CHEBI:9738


subject: CHEBI:9738


subject: CHEBI:9738


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:168243


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:9943


subject: CHEBI:10102

subject_name: Zaleplon


subject: CHEBI:10102


subject: CHEBI:10102


subject: CHEBI:10102


subject: CHEBI:10102


subject: CHEBI:10102


subject: CHEBI:10102


subject: CHEBI:10102


subject: CHEBI:10102


subject: CHEBI:10119

subject_name: Ziprasidone


subject: CHEBI:10119


subject: CHEBI:10119


subject: CHEBI:10119


subject: CHEBI:10125

subject_name: Zolpidem


subject: CHEBI:10125


subject: CHEBI:10125


subject: CHEBI:10125


subject: CHEBI:10125


subject: CHEBI:10125


subject: CHEBI:10125


subject: CHEBI:10125


subject: CHEBI:10125


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:53762


subject: CHEBI:32315

subject_name: Zopiclone


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:32315


subject: CHEBI:59115

subject_name: Clopenthixol


subject: CHEBI:59115


subject: CHEBI:59115


subject: CHEBI:59115


subject: CHEBI:59115


subject: CHEBI:59115


subject: CHEBI:59115


subject: CHEBI:59115


subject: CHEBI:59115


subject: CHEBI:51364

subject_name: Zuclopenthixol


subject: CHEBI:51364


subject: CHEBI:51364


subject: CHEBI:51364


subject: CHEBI:51364


subject: CHEBI:51364


subject: CHEBI:51364


subject: CHEBI:51364


subject: CHEBI:51364


subject: PUBCHEM.COMPOUND:53427024

subject_name: Arimoclomol

object_name: amyotrophic lateral sclerosis


subject: CHEBI:9144

subject_name: Silibinin

object_name: Parkinson disease


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Insulin resistance


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: type 2 diabetes mellitus


subject: CHEBI:26710


subject: UMLS:C5691234

object_name: gout


subject: UMLS:C5907994

subject_name: Anti-CALRmut/Anti-CD3 Bispecific Antibody JNJ-88549968

object_name: neoplasm


subject: UMLS:C5907994

object_name: myeloproliferative neoplasm


subject: UMLS:C5907994

object_name: essential thrombocythemia


subject: UMLS:C5907994

object_name: myelofibrosis


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: Deep Venous Thrombosis Related to COVID-19


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: Low back pain


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C5785773

subject_name: CD47 Antagonist AUR103 Calcium


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:91397

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:91397

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:91397

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:2668

subject_name: Amlodipine

object_name: hepatitis C


subject: CHEBI:169833

subject_name: Deacetyldiltiazem


subject: CHEBI:169833

object_name: hypertension


subject: CHEBI:169833

object_name: Hypertension, CTCAE


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:82814


subject: CHEBI:82814


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:101278


subject: CHEBI:101278


subject: CHEBI:63610

subject_name: Misoprostol

object_name: adult acute respiratory distress syndrome


subject: CHEBI:63610

object_name: newborn respiratory distress syndrome


subject: CHEBI:6541

subject_name: Losartan

object_name: essential hypertension


subject: PUBCHEM.COMPOUND:18140

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:18140

object_name: prostate cancer


subject: CHEBI:4868

subject_name: Estramustine


subject: CHEBI:4868


subject: CHEBI:90922

subject_name: Genvoya

object_name: HIV risk


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: PUBCHEM.COMPOUND:2269

object_name: Rocky mountain spotted fever


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Corrosive injury


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol